Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Mesenchymal stromal cells in the treatment of acute GVHD

Peter Bader • 25 Oct 2019
COSTEM 2019

Peter Bader, MD, PhD, Goethe University Frankfurt, Frankfurt, Germany, discusses the use of mesenchymal stromal cells in the treatment of acute graft-versus-host disease at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Peter Bader

Transplantation in an evolving therapy landscape
1:13
Transplantation in an evolving therapy landscape
Peter Bader • 26 Oct 2019
How will CAR-T cells help us cure Ph+ ALL?
3:07
How will CAR-T cells help us cure Ph+ ALL?
Peter Bader • 25 Oct 2019
Prof. Bader’s highlights from EBMT 2019
4:13
Prof. Bader’s highlights from EBMT 2019
Peter Bader • 10 Apr 2019
The aims of the EBMT Paediatric Disease Working Party
0:57
The aims of the EBMT Paediatric Disease Working Party
Peter Bader • 9 Sep 2016
The content of VJHemOnc is intended for healthcare professionals